… therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. …
polymerase chain reaction of fusion gene transcripts for residual disease detection in …

… by quantitative reverse transcription polymerase chain reaction (Q-… disease in patients with
chronic myelogenous leukemia be used … remission after treatment with interferon-alpha. Brit J …

… Baseline reverse transcriptase-polymerase chain reaction is … It acts via competitive
inhibition at the ATP-binding site of the … therapy was found to have an incremental cost-effectiveness …

… across the globe to determine the efficacy of imatinib and second-… polymerase chain reaction
method in patients with … gene for molecular monitoring of chronic myelogenous leukaemia. …

… The polymerase chain reaction (PCR) is one of the most … the survival of CML patients treated
with interferon-alpha –based … abnormality in chronic myelogenous leukaemia identified by …

… Competitive polymerase chain reaction to estimate the … polymerase chain reaction analysis
in the monitoring of … after interferon-alpha therapy for chronic myelogenous leukemia, low …

… patient was bcr-abl positive by competitive polymerase chain … made to prevent overt leukemic
relapse, monitoring of minimal … between pretransplant interferon-alpha and outcome after …

… used reverse transcription polymerase chain reaction (RT-… in a patient who developed
Ph-negative acute lymphoblastic … interferon-alpha (IFN-α) combined with hydroxyurea therapy. …

… real-time quantitative polymerase chain reaction analysis on … for potential competing events
unrelated to CML or therapy. In … Finally, using an initial monitoring of the dose of dasatinib, …

… reverse transcriptase polymerase chain reaction (RT-PCR) for … by MC and MRD is more
efficient in patients treated in early … used monitoring of MC and MRD for identification of patients …